Novavax COVID-19 vaccine (Nuvaxovid) has been provisionally approved by the Australian Therapeutic Goods Agency (TGA) for use in adolescents aged 12 to 17 years. The
Novavax has been approved as a COVID-19 booster for people aged 18 and above. In a statement released on Tuesday, Novavax announced the Therapeutic Goods Administration had
The Australian Technical Advisory Group on Immunisation (ATAGI) has recommended the use of the Novavax vaccine as a booster in Australians aged 18 and over
The first shipment of the Novavax COVID vaccine arrived in Australia last night ahead of the rollout later this month. The shipment, containing about 3 million
Australians aged 18+ will now have access to a fourth COVID-19 vaccine, Nuvaxovid (Novavax) in coming weeks, after the Australian Government accepted advice from the
Australians who are severely immunocompromised will be offered the option to receive a third COVID-19 vaccine dose to boost their protection against COVID-19 to the
Healthcare Channel – Sharing knowledge and resources for Australia’s health and aged care sector
We always welcome thought leaders ready to mentor the next generation. Be a Healthcare Channel learning partner today!
Healthcare Channel acknowledges the traditional custodians of the lands where we live, learn and work. We pay our respects to Elders past, present and emerging.
Healthcare Channel acknowledges the traditional custodians of the lands where we live, learn and work. We pay our respects to Elders past, present and emerging.
